Tags

Type your tag names separated by a space and hit enter

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.
Ann Intern Med. 2020 06 16; 172(12):819-821.AIM

Links

Publisher Full Text
ncbi.nlm.nih.gov
acpjournals.org
PMC Free PDF
Aggregator Full Text

Authors+Show Affiliations

Kim AHJ
Washington University School of Medicine, St. Louis, Missouri (A.H.K.).
Sparks JA
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (J.A.S.).
Liew JW
University of Washington, Seattle, Washington (J.W.L.).
Putman MS
Northwestern Medicine, Chicago, Illinois (M.S.P.).
Berenbaum F
Sorbonne University, Inserm CRSA, AP-HP Saint-Antoine Hospital, Paris, France (F.B.).
Duarte-García A
Mayo Clinic, Rochester, Minnesota (A.D.).
Graef ER
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (E.R.G.).
Korsten P
University Medical Center Göttingen, Göttingen, Germany (P.K.).
Sattui SE
Hospital for Special Surgery, New York, New York (S.E.S.).
Sirotich E
McMaster University, Hamilton, and Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada (E.S.).
Ugarte-Gil MF
School of Medicine, Universidad Científica del Sur and Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Peru (M.F.U.).
Webb K
University of Cape Town, Cape Town, South Africa, and the Francis Crick Institute, London, United Kingdom (K.W.).
Grainger R
University of Otago, Wellington, New Zealand (R.G.).

MeSH

Antiviral AgentsAzithromycinBetacoronavirusCOVID-19Clinical Trials as TopicConfounding Factors, EpidemiologicCoronavirus InfectionsHumansHydroxychloroquineInformation DisseminationMass MediaPandemicsPneumonia, ViralResearch DesignSARS-CoV-2

Pub Type(s)

Editorial

Language

eng

PubMed ID

32227189

Clinical Trial Links

Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting

Citation

Kim, Alfred H J., et al. "A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19." Annals of Internal Medicine, vol. 172, no. 12, 2020, pp. 819-821.
Kim AHJ, Sparks JA, Liew JW, et al. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020;172(12):819-821.
Kim, A. H. J., Sparks, J. A., Liew, J. W., Putman, M. S., Berenbaum, F., Duarte-García, A., Graef, E. R., Korsten, P., Sattui, S. E., Sirotich, E., Ugarte-Gil, M. F., Webb, K., & Grainger, R. (2020). A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Annals of Internal Medicine, 172(12), 819-821. https://doi.org/10.7326/M20-1223
Kim AHJ, et al. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 06 16;172(12):819-821. PubMed PMID: 32227189.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. AU - Kim,Alfred H J, AU - Sparks,Jeffrey A, AU - Liew,Jean W, AU - Putman,Michael S, AU - Berenbaum,Francis, AU - Duarte-García,Alí, AU - Graef,Elizabeth R, AU - Korsten,Peter, AU - Sattui,Sebastian E, AU - Sirotich,Emily, AU - Ugarte-Gil,Manuel F, AU - Webb,Kate, AU - Grainger,Rebecca, Y1 - 2020/03/30/ PY - 2020/4/1/pubmed PY - 2020/7/1/medline PY - 2020/4/1/entrez KW - Antimalarials KW - Biomarkers KW - COVID-19 KW - Chloroquine KW - Intensive care units KW - Metastasis KW - Polymerase chain reaction KW - Post-exposure prophylaxis KW - Safety KW - Viral load SP - 819 EP - 821 JF - Annals of internal medicine JO - Ann Intern Med VL - 172 IS - 12 SN - 1539-3704 UR - https://www.unboundmedicine.com/medline/citation/32227189/A_Rush_to_Judgment_Rapid_Reporting_and_Dissemination_of_Results_and_Its_Consequences_Regarding_the_Use_of_Hydroxychloroquine_for_COVID_19_ L2 - https://www.acpjournals.org/doi/10.7326/M20-1223?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -